Infection and Drug Resistance

Scope & Guideline

Uncovering insights into drug efficacy and resistance mechanisms.

Introduction

Immerse yourself in the scholarly insights of Infection and Drug Resistance with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1178-6973
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationINFECT DRUG RESIST / Infect. Drug Resistance
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Infection and Drug Resistance' focuses on the critical intersection of infectious diseases and antimicrobial resistance, providing a platform for research that contributes to the understanding, prevention, and treatment of infections. The journal emphasizes the need for innovative approaches in combating drug-resistant pathogens, aligning with contemporary global health challenges.
  1. Antimicrobial Resistance Mechanisms:
    Research on the genetic and phenotypic mechanisms of antimicrobial resistance in various pathogens, including bacteria, fungi, and viruses, is a primary focus, aiming to elucidate the pathways through which resistance develops and spreads.
  2. Infectious Disease Epidemiology:
    The journal publishes studies that analyze the epidemiological trends of infectious diseases, including their transmission dynamics, risk factors, and the impact of social and environmental determinants on disease outbreaks.
  3. Clinical Outcomes and Treatment Strategies:
    Articles explore clinical outcomes associated with different treatment regimens for infections, particularly those caused by multidrug-resistant organisms, and evaluate the efficacy and safety of novel therapeutic agents.
  4. Diagnostic Innovations:
    There is a strong focus on the development and validation of new diagnostic methods, including molecular techniques such as metagenomic next-generation sequencing, aimed at improving the speed and accuracy of pathogen identification.
  5. Public Health Interventions:
    The journal highlights studies on public health interventions and strategies for infection prevention and control, particularly in healthcare settings, to mitigate the impact of drug-resistant infections.
  6. Global Health Perspectives:
    Research articles often incorporate global health perspectives, addressing the challenges of infectious diseases and antimicrobial resistance in various geographical and socio-economic contexts.
The journal has seen a notable evolution in its focus areas, reflecting current global health challenges and emerging scientific advancements. This section outlines the new trends and topics that are increasingly becoming central to the journal's publications.
  1. Metagenomic Approaches:
    There is a rising trend in the application of metagenomic next-generation sequencing for diagnosing complex infections, allowing for a more comprehensive understanding of microbial communities and resistance profiles.
  2. Machine Learning and AI in Infectious Diseases:
    The integration of machine learning and artificial intelligence in predicting infection outcomes and resistance patterns is gaining traction, with studies exploring how these technologies can enhance clinical decision-making.
  3. Impact of COVID-19 on Other Infections:
    Research examining the impact of the COVID-19 pandemic on the epidemiology and management of other infectious diseases, including the resurgence of previously controlled infections, is increasingly relevant.
  4. Vaccination Strategies and Acceptance:
    With the ongoing vaccination efforts against COVID-19 and other infectious diseases, research on vaccine uptake, acceptance, and the associated factors is becoming a significant focus area.
  5. One Health Approach:
    The journal is increasingly publishing articles that adopt a One Health perspective, addressing the interconnectedness of human, animal, and environmental health in the context of infectious diseases and antimicrobial resistance.
  6. Public Health Strategies for Infection Control:
    There is a growing emphasis on evaluating and developing public health strategies and interventions for infection prevention and control, particularly in healthcare settings and during outbreaks.

Declining or Waning

While 'Infection and Drug Resistance' has maintained a robust focus on antimicrobial resistance and infectious diseases, certain areas of research have seen a decline in publication frequency or relevance. These waning scopes highlight shifts in research priorities or emerging challenges that may overshadow previously popular topics.
  1. Traditional Antibiotic Approaches:
    Research focusing solely on conventional antibiotic therapies without considering resistance mechanisms or the need for combination therapies has declined as the field shifts towards more integrated approaches to combat resistance.
  2. Single-Agent Studies:
    Studies evaluating the efficacy of single-agent antibiotic therapies have become less frequent as the understanding of polymicrobial infections and the need for combination therapies gains prominence.
  3. Basic Laboratory Research:
    There is a noticeable decline in purely basic laboratory studies that do not translate into clinical relevance or application, as the journal increasingly prioritizes translational research with direct implications for patient care.
  4. Historical Epidemiological Data:
    Research that focuses solely on historical epidemiological data without providing insights into current trends or implications for practice appears to be waning, reflecting a shift towards real-time data analysis and its application in public health.

Similar Journals

ACS Infectious Diseases

Exploring Innovations in Infectious Disease Solutions
Publisher: AMER CHEMICAL SOCISSN: 2373-8227Frequency: 12 issues/year

ACS Infectious Diseases is a premier journal in the field of infectious diseases, published by the American Chemical Society. With an impressive Impact Factor that places it in the Q1 category for Infectious Diseases in 2023, the journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of infectious agents and their impact on public health. Established in 2015, the journal is committed to publishing cutting-edge research that enhances our understanding of infectious diseases and fosters the development of innovative interventions. Although not an open access journal, it provides a platform for high-quality research that influences policies and practices in the field. With an address located at 1155 16TH ST, NW, WASHINGTON, DC 20036, ACS Infectious Diseases is an authoritative voice in advancing the science and practice of infectious disease management.

Infection and Chemotherapy

Pioneering Research in Infectious Diseases and Pharmacology
Publisher: KOREAN SOC ANTIMICROBIAL THERAPYISSN: 2093-2340Frequency: 4 issues/year

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

International Journal of Antimicrobial Agents

Connecting Researchers and Clinicians in the Battle Against Infections
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Mediterranean Journal of Infection Microbes and Antimicrobials

Exploring the intricate world of microbes and health.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Antimicrobial Resistance and Infection Control

Uniting experts to combat the global health crisis.
Publisher: BMCISSN: 2047-2994Frequency: 1 issue/year

Antimicrobial Resistance and Infection Control is a leading open access journal published by BMC, dedicated to the dissemination of research in the critical area of antimicrobial resistance and its impact on infection control practices. Since its inception in 2012, the journal has quickly established itself as a vital resource for researchers, healthcare professionals, and policymakers, featuring a robust array of studies that address the escalating threats posed by antimicrobial resistance across various contexts. With its impressive Q1 rankings across multiple categories—including Infectious Diseases, Microbiology, Pharmacology, and Public Health—the journal’s influence is underscored by its consistent placement in the upper echelons of academic research. Furthermore, it holds commendable ranks in Scopus, with percentiles placing it in the top tier of its respective fields. The journal serves as an essential platform for innovative research and discussions aimed at curbing the threats of antimicrobial resistance, thereby supporting the global health community in striving for effective solutions to safeguard public health.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Exploring the frontiers of microbial interactions.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

JOURNAL OF CLINICAL MICROBIOLOGY

Pioneering Research for Tomorrow's Healthcare
Publisher: AMER SOC MICROBIOLOGYISSN: 0095-1137Frequency: 12 issues/year

JOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Exploring Innovations in Diagnostic Microbiology
Publisher: ELSEVIER SCIENCE INCISSN: 0732-8893Frequency: 12 issues/year

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Infektsiya i Immunitet

Advancing knowledge in immunology and infectious diseases.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

CLINICAL MICROBIOLOGY AND INFECTION

Transforming Knowledge into Clinical Practice
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.